Home- Research
- Conferences
- Workshops & Training
- Program
- Overview
- *Innovation Cafe
- Drug Safety
- Counterfeit Drugs
- Valuation & Auditing
- Drug Discovery Innovation
- Drug Development
- Complex Systems & Org. Development
- Semantic Web
- R&D Knowledge Management
- Abstracts
- Speakers
- Allemand, P
- Barrett, J
- Gardner, S
- Gates, P
- Gibbs, A
- Hardy, B
- Henrick, K
- Jautelat, R
- Jordis, U
- Kanagy, J
- Liebman, M
- Montano, B
- Newman, V
- Polsky-Newman, R
- Scoffin, R
- Sharp, M
- Spitzner, J
- Starry, S
- Weintraub, H
- Wikel, J
- Molecular Medicine
- Nanobiotech
- Personalised Medicine
- Exhibition
- Registration
- About
- Overview
- Contact
- Support
- Schedule
|
|
|
|
|
|
|
|
|
| Scott K. Starry, Ph.D., Senior Product Manager, Symyx IntelliChem, Inc. |
|
| Scott Starry joined Symyx IntelliChem in 2004 to lead the product management team for Pharmaceutical Discovery. Prior to joining Symyx IntelliChem, Scott spent 13+ years supporting pharmaceutical companies. He spent nearly seven years at Tripos doing algorithm development, technical support, customer specific projects, and market development. Scott then moved to Tularik (now Amgen SF) where he was responsible for developing, integrating, and supporting applications for chemical databases, inventory systems, high throughput screening, and SAR studies. Scott holds both a Ph.D. and M.S. in Polymer Science and Engineering (University of Massachusetts, Amherst) as well as a B.Ch.E. in Chemical Engineering and a B.A.A.S. in Philosophy (University of Delaware).
|
|
|
|
Global information integration in R&D
Scott K Starry, Ph.D., Senior Product Manager, Symyx IntelliChem, Inc.
The pharmaceutical industry is facing a formidable challenge. On one hand, it is important to gather more and more information at each step of the R&D process, on the other hand, this information is important to more and more people along the complex drug discovery and design chain. This exponential increase in information sharing, compounded by the introduction of parallel methods at all stages of the process, requires a change in mentality about how to deal with knowledge in a pharmaceutical R&D organisation.
This presentation will discuss how such global information flows can be handled and what impact handling those has, both on the way of working and the way of thinking that corporations have to introduce to survive. It will also cover examples of how a global information management network can help companies reach the next level necessary in this context. Some pitfalls and dangers of information strategies will be explored to illustrate this vision.
|
|
|
|
|
|
|
